Candel Therapeutics, Inc. (CADL) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$38.18M | +30.8% |
| 2024 | -$55.18M | -45.4% |
| 2023 | -$37.94M | -101.9% |
| 2022 | -$18.79M | +48.0% |
| 2021 | -$36.12M | -104.3% |
| 2020 | -$17.68M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$38.18M | +30.8% |
| 2024 | -$55.18M | -45.4% |
| 2023 | -$37.94M | -101.9% |
| 2022 | -$18.79M | +48.0% |
| 2021 | -$36.12M | -104.3% |
| 2020 | -$17.68M | — |